|
|
Previous Article | Table of Contents | Next Article 
Erythropoietin mRNA levels are governed by both the rate of gene
transcription and posttranscriptional events
MA Goldberg, CC Gaut and HF Bunn
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
The human hepatoma cell line, Hep3B, synthesizes large quantities of
erythropoietin (Epo) mRNA and protein in a regulated manner in response to
hypoxia and cobaltous chloride (CoCl2). To further understand the
regulation of Epo gene expression, we studied the effects of hypoxia and
CoCl2 on the rate of Epo gene transcription. While Northern blot analyses
showed that steady-state Epo mRNA levels increase more than 50- fold in
response to hypoxia or CoCl2, nuclear run-off experiments demonstrated only
a 10-fold increase in Epo gene transcription in response to these stimuli.
In the presence of either actinomycin D (Act D) or cycloheximide, the
stability of biologically functional Epo mRNA was much greater than that
observed in the absence of these agents and much greater than that which
has been reported in vivo. These findings suggest that the stability of Epo
mRNA is modulated by the transcription and translation of rapidly turning
over gene product(s). Thus, Epo mRNA levels are determined by both the rate
of gene transcription and posttranscriptional events. These experiments
demonstrate a potential pitfall in estimating mRNA half-lives based on Act
D chase experiments alone.
Volume 77,
Issue 2,
pp. 271-277,
01/15/1991
Copyright © 1991 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Duan and C. R Jefcoate
The predominant cAMP-stimulated 3.5 kb StAR mRNA contains specific sequence elements in the extended 3'UTR that confer high basal instability
J. Mol. Endocrinol.,
January 1, 2007;
38(1):
159 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Al-Huniti, J. A. Widness, R. L. Schmidt, and P. Veng-Pedersen
Pharmacokinetic/Pharmacodynamic Analysis of Paradoxal Regulation of Erythropoietin Production in Acute Anemia
J. Pharmacol. Exp. Ther.,
July 1, 2004;
310(1):
202 - 208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Shams, A. Avivi, and E. Nevo
Hypoxic stress tolerance of the blind subterranean mole rat: Expression of erythropoietin and hypoxia-inducible factor 1{alpha}
PNAS,
June 29, 2004;
101(26):
9698 - 9703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Daniels, A. D. Cambrey, N. L. Occleston, Q. Garrett, R. W. Tarnuzzer, G. S. Schultz, and P. T. Khaw
Matrix Metalloproteinase Inhibition Modulates Fibroblast-Mediated Matrix Contraction and Collagen Production In Vitro
Invest. Ophthalmol. Vis. Sci.,
March 1, 2003;
44(3):
1104 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sugawara, S. I. Tazuke, L. F-Suen, D. R. Powell, F. Kaper, A. J. Giaccia, and L. C. Giudice
Regulation of Insulin-Like Growth Factor-Binding Protein 1 by Hypoxia and 3',5'-Cyclic Adenosine Monophosphate Is Additive in HepG2 Cells
J. Clin. Endocrinol. Metab.,
October 1, 2000;
85(10):
3821 - 3827.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Gupta, P. T. Mungai, and E. Goldwasser
A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene
Blood,
July 15, 2000;
96(2):
491 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Steinbrech, B. J. Mehrara, P. B. Saadeh, J. A. Greenwald, J. A. Spector, G. K. Gittes, and M. T. Longaker
VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism
Am J Physiol Cell Physiol,
April 1, 2000;
278(4):
C853 - C860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Landau, R. Tirosh, A. Pinson, S. Banai, S. Even-Ram, M. Maoz, S. Katzav, and R. Bar-Shavit
Protection of Thrombin Receptor Expression under Hypoxia
J. Biol. Chem.,
January 28, 2000;
275(4):
2281 - 2287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Panchenko, H. W. Farber, and J. H. Korn
Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts
Am J Physiol Cell Physiol,
January 1, 2000;
278(1):
C92 - C101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yin and K. L. Blanchard
DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms
Blood,
January 1, 2000;
95(1):
111 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Ebert and H. F. Bunn
Regulation of the Erythropoietin Gene
Blood,
September 15, 1999;
94(6):
1864 - 1877.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R Kersten, P. S Pagel, W. M Chilian, and D. C Warltier
Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia
Cardiovasc Res,
July 1, 1999;
43(1):
44 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oh, H. Takagi, K. Suzuma, A. Otani, M. Matsumura, and Y. Honda
Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells
J. Biol. Chem.,
May 28, 1999;
274(22):
15732 - 15739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Dibbens, D. L. Miller, A. Damert, W. Risau, M. A. Vadas, and G. J. Goodall
Hypoxic Regulation of Vascular Endothelial Growth Factor mRNA Stability Requires the Cooperation of Multiple RNA Elements
Mol. Biol. Cell,
April 1, 1999;
10(4):
907 - 919.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. F. Czyzyk-Krzeska and A. C. Bendixen
Identification of the Poly(C) Binding Protein in the Complex Associated With the 3' Untranslated Region of Erythropoietin Messenger RNA
Blood,
March 15, 1999;
93(6):
2111 - 2120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Thrash-Bingham and K. D. Tartof
aHIF: a Natural Antisense Transcript Overexpressed in Human Renal Cancer and During Hypoxia
J Natl Cancer Inst,
January 20, 1999;
91(2):
143a - 151a.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krieg, H. H. Marti, and K. H. Plate
Coexpression of Erythropoietin and Vascular Endothelial Growth Factor in Nervous System Tumors Associated With von Hippel-Lindau Tumor Suppressor Gene Loss of Function
Blood,
November 1, 1998;
92(9):
3388 - 3393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Murone, D. A. Carpenter, and F. J. de Sauvage
Hematopoietic Deficiencies in c-mpl and TPO Knockout Mice
Stem Cells,
January 1, 1998;
16(1):
1 - 6.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. C. McGary, I. J. Rondon, and B. S. Beckman
Post-transcriptional Regulation of Erythropoietin mRNA Stability by Erythropoietin mRNA-binding Protein
J. Biol. Chem.,
March 28, 1997;
272(13):
8628 - 8634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Semenza, B.-H. Jiang, S. W. Leung, R. Passantino, J.-P. Concordet, P. Maire, and A. Giallongo
Hypoxia Response Elements in the Aldolase A, Enolase 1,and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1
J. Biol. Chem.,
December 20, 1996;
271(51):
32529 - 32537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Rajagopalan and J. S. Malter
Turnover and Translation of in Vitro Synthesized Messenger RNAs in Transfected, Normal Cells
J. Biol. Chem.,
August 16, 1996;
271(33):
19871 - 19876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-H. Jiang, E. Rue, G. L. Wang, R. Roe, and G. L. Semenza
Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1
J. Biol. Chem.,
July 26, 1996;
271(30):
17771 - 17778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Levy, N. S. Levy, and M. A. Goldberg
Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia
J. Biol. Chem.,
February 2, 1996;
271(5):
2746 - 2753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Wenger, A. Rolfs, H. H. Marti, C. Bauer, and M. Gassmann
Hypoxia, a Novel Inducer of Acute Phase Gene Expression in a Human Hepatoma Cell Line
J. Biol. Chem.,
November 17, 1995;
270(46):
27865 - 27870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Levy, N. S. Levy, S. Wegner, and M. A. Goldberg
Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia
J. Biol. Chem.,
June 2, 1995;
270(22):
13333 - 13340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Ho, A. Acquaviva, E. Duh, and H. F. Bunn
Use of a Marked Erythropoietin Gene for Investigation of Its Cis-acting Elements
J. Biol. Chem.,
April 28, 1995;
270(17):
10084 - 10090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Wang and G. L. Semenza
Purification and Characterization of Hypoxia-inducible Factor 1
J. Biol. Chem.,
January 20, 1995;
270(3):
1230 - 1237.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|